"Recurrent ovarian cancer" trang 1 - tải miễn phí từ tailieunhanh
Rucaparib in recurrent ovarian cancer: Real-world experience from the rucaparib early access programme in Spain – A GEICO study

Rucaparib in recurrent ovarian cancer: Real-world experience from the rucaparib early access programme in Spain – A GEICO study
10    9    1
Study protocol for prospective multi-institutional phase III trial of standard of care therapy with or without stereotactic ablative radiation therapy for recurrent ovarian cancer (SABR-ROC)

Study protocol for prospective multi-institutional phase III trial of standard of care therapy with or without stereotactic ablative radiation therapy for recurrent ovarian cancer (SABR-ROC)
7    3    1
BK-UM in patients with recurrent ovarian cancer or peritoneal cancer: A first-inhuman phase-I study

BK-UM in patients with recurrent ovarian cancer or peritoneal cancer: A first-inhuman phase-I study
8    42    1
Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer

Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer
12    94    0
Hereditary breast and ovarian cancer in Andalusian families: A genetic population study

Hereditary breast and ovarian cancer in Andalusian families: A genetic population study
12    49    1
High OX40 expression in recurrent ovarian carcinoma is indicative for response to repeated chemotherapy

High OX40 expression in recurrent ovarian carcinoma is indicative for response to repeated chemotherapy
9    42    1
Stromal cell ratio based on automated image analysis as a predictor for platinumresistant recurrent ovarian cancer

Stromal cell ratio based on automated image analysis as a predictor for platinumresistant recurrent ovarian cancer
8    76    1
A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer

A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer
7    42    1
Cytoreductive surgery followed by chemotherapy versus chemotherapy alone for recurrent platinum-sensitive epithelial ovarian cancer (SOCceR trial): A multicenter randomised controlled study

Cytoreductive surgery followed by chemotherapy versus chemotherapy alone for recurrent platinum-sensitive epithelial ovarian cancer (SOCceR trial): A multicenter randomised controlled study
7    38    1
Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain)

Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain)
10    50    1
A phase IA dose-escalation study of PHI101, a new checkpoint kinase 2 inhibitor, for platinum-resistant recurrent ovarian cancer

A phase IA dose-escalation study of PHI101, a new checkpoint kinase 2 inhibitor, for platinum-resistant recurrent ovarian cancer
7    31    3
Exome profiling of primary, metastatic and recurrent ovarian carcinomas in a BRCA1-positive patient

Exome profiling of primary, metastatic and recurrent ovarian carcinomas in a BRCA1-positive patient
11    46    1
Prevalence of specific and recurrent/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North Africa

Prevalence of specific and recurrent/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North Africa
19    19    1
Identification of recurrent focal copy number variations and their putative targeted driver genes in ovarian cancer

Identification of recurrent focal copy number variations and their putative targeted driver genes in ovarian cancer
12    39    1